Medy Tox (Korea) Market Value
| 086900 Stock | KRW 128,800 1,600 1.26% |
| Symbol | Medy |
Medy Tox 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medy Tox's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medy Tox.
| 04/03/2023 |
| 11/23/2024 |
If you would invest 0.00 in Medy Tox on April 3, 2023 and sell it all today you would earn a total of 0.00 from holding Medy Tox or generate 0.0% return on investment in Medy Tox over 600 days. Medy Tox is related to or competes with Genexine, Busan Industrial, UNISEM, Finebesteel, Fine Besteel, and Hyundai Heavy. Medy-Tox Inc., a biopharmaceutical company, develops, manufactures, markets, and sells botulinum toxin and hyaluronic ac... More
Medy Tox Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medy Tox's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medy Tox upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 21.53 | |||
| Value At Risk | (4.34) | |||
| Potential Upside | 6.19 |
Medy Tox Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medy Tox's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medy Tox's standard deviation. In reality, there are many statistical measures that can use Medy Tox historical prices to predict the future Medy Tox's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (0.95) | |||
| Treynor Ratio | 0.5963 |
Medy Tox Backtested Returns
Medy Tox has Sharpe Ratio of -0.2, which conveys that the firm had a -0.2% return per unit of risk over the last 3 months. Medy Tox exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Medy Tox's Standard Deviation of 3.57, risk adjusted performance of (0.09), and Mean Deviation of 2.68 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.82, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Medy Tox are expected to decrease at a much lower rate. During the bear market, Medy Tox is likely to outperform the market. At this point, Medy Tox has a negative expected return of -0.71%. Please make sure to verify Medy Tox's standard deviation, total risk alpha, and the relationship between the coefficient of variation and jensen alpha , to decide if Medy Tox performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.11 |
Insignificant reverse predictability
Medy Tox has insignificant reverse predictability. Overlapping area represents the amount of predictability between Medy Tox time series from 3rd of April 2023 to 28th of January 2024 and 28th of January 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medy Tox price movement. The serial correlation of -0.11 indicates that less than 11.0% of current Medy Tox price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.11 | |
| Spearman Rank Test | -0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 585.3 M |
Medy Tox lagged returns against current returns
Autocorrelation, which is Medy Tox stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Medy Tox's stock expected returns. We can calculate the autocorrelation of Medy Tox returns to help us make a trade decision. For example, suppose you find that Medy Tox has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Medy Tox regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Medy Tox stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Medy Tox stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Medy Tox stock over time.
Current vs Lagged Prices |
| Timeline |
Medy Tox Lagged Returns
When evaluating Medy Tox's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Medy Tox stock have on its future price. Medy Tox autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Medy Tox autocorrelation shows the relationship between Medy Tox stock current value and its past values and can show if there is a momentum factor associated with investing in Medy Tox.
Regressed Prices |
| Timeline |
Pair Trading with Medy Tox
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medy Tox position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medy Tox will appreciate offsetting losses from the drop in the long position's value.Moving together with Medy Stock
Moving against Medy Stock
The ability to find closely correlated positions to Medy Tox could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medy Tox when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medy Tox - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medy Tox to buy it.
The correlation of Medy Tox is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medy Tox moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medy Tox moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medy Tox can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Medy Stock
Medy Tox financial ratios help investors to determine whether Medy Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medy with respect to the benefits of owning Medy Tox security.